Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: results from eight years of surveillance of clinical practice in the nationwide Danish DANBIO registry

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Reply

    Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

  2. Abatacept after Rituximab in rheumatoid arthritis. a Pan-European Collaboration of RA Registries.

    Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

  3. M-ficolin levels reflect disease activity and predict remission in early rheumatoid arthritis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Headache in systemic lupus erythematosus: results from a prospective, international inception cohort study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Axial involvement in patients with early peripheral spondyloarthritis: a prospective MRI study of sacroiliac joints and spine

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer
To compare tumor necrosis factor alpha inhibitors directly regarding the rates of treatment response, remission, and the drug survival rate in patients with rheumatoid arthritis (RA), and to identify clinical prognostic factors for response.
OriginalsprogEngelsk
TidsskriftArthritis & Rheumatism
Vol/bind62
Udgave nummer1
Sider (fra-til)22-32
Antal sider11
ISSN0004-3591
DOI
StatusUdgivet - 1 jan. 2010

ID: 32219357